AU1189395A - Apolipoprotein e polymorphism and alzheimer's disease - Google Patents

Apolipoprotein e polymorphism and alzheimer's disease

Info

Publication number: AU1189395A
Authority: AU; Australia
Prior art keywords: apolipoprotein; polymorphism; alzheimer; disease
Prior art date: 1993-12-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU11893/95A

Inventor

Judes Poirier

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

McGill University

Original Assignee

McGill University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-15

Filing date

1994-12-13

Publication date

1995-07-03

1994-12-13 Application filed by McGill University filed Critical McGill University

1995-07-03 Publication of AU1189395A publication Critical patent/AU1189395A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6858—Allele-specific amplification
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Analytical Chemistry (AREA)
Biophysics (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pathology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU11893/95A 1993-12-15 1994-12-13 Apolipoprotein e polymorphism and alzheimer's disease Abandoned AU1189395A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
CA2111503		1993-12-15
CA 2111503 CA2111503A1 (en)	1993-12-15	1993-12-15	Apolipoprotein e polymorphism and alzheimer's disease
PCT/CA1994/000681 WO1995016791A1 (en)	1993-12-15	1994-12-13	Apolipoprotein e polymorphism and alzheimer's disease

Publications (1)

Publication Number	Publication Date
AU1189395A true AU1189395A (en)	1995-07-03

Family

ID=4152624

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU11893/95A Abandoned AU1189395A (en)	1993-12-15	1994-12-13	Apolipoprotein e polymorphism and alzheimer's disease

Country Status (3)

Country	Link
AU (1)	AU1189395A (en)
CA (1)	CA2111503A1 (en)
WO (1)	WO1995016791A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9414624D0 (en) *	1994-07-20	1994-09-07	Smithkline Beecham Plc	Novel method
US6022683A (en) *	1996-12-16	2000-02-08	Nova Molecular Inc.	Methods for assessing the prognosis of a patient with a neurodegenerative disease
US5767337A (en) *	1995-07-31	1998-06-16	Duke University	Creation of human apolipoprotein E isoform specific transgenic mice in apolipoprotein deficient "knockout" mice
US6136530A (en) *	1995-11-29	2000-10-24	Texas Tech University Health Sciences Center	Compositions and methods for assessing risk factors in Alzheimer's disease
US6711551B1 (en)	1996-06-05	2004-03-23	Netzero, Inc.	Information provider, terminal and system and recording medium for the terminal
ES2115553B1 (en) *	1996-10-23	1999-02-16	Boehringer Ingelheim Espana	METHOD TO DETECT THE PRESENCE OF DNA POLYMORPHISMS, TEST KIT AND CORRESPONDING RECOMBINANT NUCLEIC ACIDS.
ES2128265B1 (en) *	1997-06-04	2000-03-01	Euroespes S A	GENETIC KIT FOR THE MOLECULAR CHARACTERIZATION OF ALZHEIMER'S DISEASE.
FR2765591B1 (en) *	1997-07-01	2002-08-09	Pasteur Institut	METHOD FOR DIAGNOSING ALZHEIMER'S DISEASE
ES2142248B1 (en) *	1997-11-20	2000-11-16	Univ Madrid Autonoma	POLYMORPHISMS IN THE PROMOTER OF THE HUMAN GENE OF APOLIPOPROTEIN E, AND ITS USES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS.
US6251587B1 (en)	1997-12-16	2001-06-26	Nova Molecular, Inc.	Method for determining the prognosis of a patient with a neurological disease
DE19855469C2 (en) *	1998-12-01	2001-01-11	Michael Esrich	Method for determining the apolipoprotein E genotype in a human sample
EP1364046B1 (en) *	2000-05-23	2011-11-30	Variagenics, Inc.	Methods for genetic analysis of dna to detect sequence variances
US7435541B2 (en)	2000-05-23	2008-10-14	Sequenom, Inc.	Restriction enzyme genotyping
WO2004003229A2 (en) *	2002-06-27	2004-01-08	Aarhus Universitet	Disease risk estimating method using sequence polymorphisms in a specific region of chromosome 19
DE60328198D1 (en) *	2002-08-07	2009-08-13	Novartis Ag	A method of predicting treatment success with rivastigmine based on a determination of the apoE genotype of a dementia patient
US7592141B2 (en) *	2004-12-13	2009-09-22	Duke University	Methods of identifying individuals at reduced risk of sepsis
AU2020228660A1 (en) *	2019-02-28	2021-08-26	Inspirna, Inc.	APOE genotyping in cancer prognostics and treatment
US11174220B2 (en)	2019-12-13	2021-11-16	Inspirna, Inc.	Metal salts and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL97222A (en) *	1990-02-16	1995-08-31	Orion Yhtymae Oy	Method and reagent for determining specific nucleotide variations
DE625212T1 (en) *	1992-10-13	2000-11-02	Duke University, Durham	METHOD FOR DISCOVERING DISEASE OF ALZHEIMER.

1993
- 1993-12-15 CA CA 2111503 patent/CA2111503A1/en not_active Abandoned
1994
- 1994-12-13 WO PCT/CA1994/000681 patent/WO1995016791A1/en not_active Ceased
- 1994-12-13 AU AU11893/95A patent/AU1189395A/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2111503A1 (en)	1995-06-16
WO1995016791A1 (en)	1995-06-22

Publication	Publication Date	Title
ZA9410095B (en)	1996-06-19	Methods of inhibiting Alzheimer's Disease
HU9302551D0 (en)	1993-11-29	Compounds having effect against hypoglycemia and alzheimer's disease
AU1189395A (en)	1995-07-03	Apolipoprotein e polymorphism and alzheimer's disease
AU1407399A (en)	1999-06-07	Treatment for alzheimer's disease
AU5508798A (en)	1998-06-10	Diagnostic and therapeutic reagents for alzheimer's disease
AU7397094A (en)	1995-03-22	Prevention and treatment of alzheimer's disease
PL304881A1 (en)	1995-03-20	Turbocompressor
AU1322695A (en)	1995-07-17	Polycystic kidney disease 1 gene and uses thereof
AU6268694A (en)	1994-09-26	Swimmer's aid
AU7556994A (en)	1995-03-14	Methods for the diagnosis of alzheimer's disease
AU4636993A (en)	1994-01-04	Diagnosing alzheimer's disease and schizophrenia
AU4012795A (en)	1996-05-23	Alzheimer's peptide
AU6401696A (en)	1997-02-10	Early onset alzheimer's disease gene and gene products
GB9606935D0 (en)	1996-06-05	Flatmate' computer
AU3500497A (en)	1998-01-07	Hodgkin's disease associated molecules and uses thereof
GB9207115D0 (en)	1992-05-13	Driver's aid
AU1072195A (en)	1995-06-06	Diagnosis of alzheimer's disease
AU8700998A (en)	1998-12-03	Use of Apolipoprotein polymorphism E in the treatment of Alzheimer's disease
DE69405544D1 (en)	1997-10-16	4'-0-sulfonylanthracyclinderivate
GB9304699D0 (en)	1993-04-28	"i need help" sign
AU7467094A (en)	1995-03-14	Method of diagnosing alzheimer's disease
AUPM938594A0 (en)	1994-12-08	Smokehood 173
GB9314869D0 (en)	1993-09-01	The "x" scew and "x" driver
GB9304930D0 (en)	1993-04-28	Graingier's denium sierum
ZA944000B (en)	1995-02-03	"Support"